Renew X Pharma has launched a new website, offering a user-friendly platform for individuals seeking reliable wellness products. From anti-estrogen aids to peptides and post-cycle therapy ...

Live webcasts of the fireside chats will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of ...

Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma ...

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 13, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, ...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced its business update and financial ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...

Renew X Pharma has launched a new website, offering a user-friendly platform for individuals seeking reliable wellness products. From anti-estrogen aids to peptides and post-cycle therapy solutions, ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Amphastar Pharmaceuticals, Inc. - 10-Q, Quarterly Report 06.11. Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 ...

Some are more clear than others. President-elect Donald Trump ’s nomination of Robert F. Kennedy Jr. as head of the ...

Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...